PRESS RELEASE published on 06/20/2024 at 15:15, 4 months 19 days ago Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics Applied DNA and Alphazyme announce successful conclusion of Linea RNAP manufacturing scale-up agreement, resulting in over 70% cost reduction and sufficient quantity for near-term demand. Partnership enhances Linea IVT platform profitability Biotechnology MRNA Production Alphazyme Linea RNAP Applied DNA
BRIEF published on 06/18/2024 at 15:05, 4 months 21 days ago Applied DNA s'associe à GenXys pour l'aide à la décision clinique dans les tests PGx ADN Appliqué TR8 PGx Tests Pharmacogénomiques GenXys Prescription De Précision
BRIEF published on 06/18/2024 at 15:05, 4 months 21 days ago Applied DNA Partners with GenXys for Clinical Decision Support in PGx Testing Applied DNA Pharmacogenomic Testing TR8 PGx GenXys Precision Prescribing
PRESS RELEASE published on 06/18/2024 at 15:00, 4 months 21 days ago Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing Applied DNA partners with GenXys Health Care Systems to enhance precision prescribing decisions through TR8 PGx test. The partnership aims to improve patient outcomes and reduce healthcare costs Healthcare Applied DNA Precision Prescribing GenXys Health Care Systems PGx Test
BRIEF published on 06/13/2024 at 15:05, 4 months 26 days ago Applied DNA reçoit l'approbation du service de tests pharmacogénomiques TR8™ du ministère de la Santé de l'État de New York Soins De Santé Sciences Appliquées De L'ADN TR8 PGx Tests Pharmacogénomiques État De New York
BRIEF published on 06/13/2024 at 15:05, 4 months 26 days ago Applied DNA Receives Approval for TR8™ Pharmacogenomic Testing Service from New York State Department of Health New York State Healthcare Applied DNA Sciences Pharmacogenomic Testing TR8 PGx
PRESS RELEASE published on 06/13/2024 at 15:00, 4 months 26 days ago Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health Applied DNA Sciences, Inc. receives approval from NYSDOH for TR8 PGx testing service targeting enterprise customers and healthcare networks in New York State, offering personalized medication guidance based on genetic testing Applied DNA Sciences Personalized Medicine Pharmacogenomic Testing TR8 PGx New York State Department Of Health
BRIEF published on 06/05/2024 at 15:05, 5 months 4 days ago Applied DNA Receives Notice of Allowance for Key U.S. Patent Patent MRNA Production Linea IVT Applied DNA RNA Polymerase
BRIEF published on 06/05/2024 at 15:05, 5 months 4 days ago Applied DNA reçoit un avis d'acceptation pour un brevet américain clé Brevet Production D'ARNm ADN Appliqué Ligne IVT ARN Polymérase
PRESS RELEASE published on 06/05/2024 at 15:00, 5 months 4 days ago Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea(TM) IVT Platform Applied DNA Sciences, Inc. receives Notice of Allowance for patent covering Linea™ RNAP composition empowering Linea™ IVT Platform. Patent protection extends to 2041 Patent MRNA Production Applied DNA Sciences Inc. Linea™ RNAP Linea™ IVT Platform
Published on 11/09/2024 at 16:30, 1 hour 12 minutes ago New to the Street Premieres Episode 611 on Bloomberg Television Tonight at 6:30 PM EST, Featuring Zapp Electric Vehicles, OriginClea and PillSafe
Published on 11/09/2024 at 04:00, 13 hours 42 minutes ago Freedom Holding Corp. Reports Second Quarter Fiscal Year 2025 Financial Results
Published on 11/08/2024 at 23:05, 18 hours 37 minutes ago Murchison Minerals Announces Non-Brokered Private Placement
Published on 11/08/2024 at 20:15, 21 hours 27 minutes ago Able View Global Inc. Raises USD$4 Million from Convertible Notes Financing to Propel Growth
Published on 11/08/2024 at 18:35, 23 hours 7 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/08/2024 at 18:20, 23 hours 22 minutes ago ENCAVIS achieves results in the first three quarters of 2024 below the figures for the same period of the previous year due to unforeseeable events and adjusts guidance for the current financial year
Published on 11/08/2024 at 18:02, 23 hours 40 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/08/2024 at 18:00, 23 hours 42 minutes ago 2CRSi SA: Provision of the Financial Report
Published on 11/08/2024 at 18:00, 23 hours 42 minutes ago Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 11/08/2024 at 18:00, 23 hours 42 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 11/08/2024 at 17:52, 23 hours 50 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2024
Published on 11/08/2024 at 17:52, 23 hours 50 minutes ago Capital et droits de vote au 31 octobre 2024
Published on 11/08/2024 at 17:45, 23 hours 57 minutes ago CHARGEURS - Voting rights monthly statement as of October 31st, 2024